HLS Therapeutics Inc (HLS)
$3.50 $0.09 (2.64%) 4:40 PM 12/11/24
TSX | $CAD | Drug Manufacturers - Specialty & GenericStock Data
-
Market Cap
$109.69M -
Day's Range
CA$3.25 - CA$3.55 -
Volume
40,339 -
52 Week Low / High
CA$3.00 - CA$5.48 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
quarterly
HLS's Dividend
Company News
-
HLS Therapeutics Announces CFO Departure — Dec 18th, 2023
John Hanna appointed Interim CFO to replace departing CFO Tim Hendrickson TORONTO, Dec. 18, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular dis...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$